A Study to Assess Safety, Tolerability and PK of AZD2171 and Chemotherapy on Patients With Solid Tumors
Status:
Completed
Trial end date:
2011-06-01
Target enrollment:
Participant gender:
Summary
A multicentre, 2-part study to assess the safety and tolerability of once daily oral doses of
AZD2171 when administered with various anticancer regimens (part A) and to confirm the
tolerability of its combination with FOLFOX (part B).